Nonspecific host defenses in surgical cancer patients

Gatti, 1979, Occurrence of malignancy in immunodeficiency diseases: A literature review, Cancer, 28, 89, 10.1002/1097-0142(197107)28:1<89::AID-CNCR2820280117>3.0.CO;2-Q Penn, 1982, Immune Deficiencies, Curr. Probl. Cancer, VI Howard, 1980, Host defense against infection—Part I, Curr. Probl. Surg., 17, 267 Howard, 1980, Host defense against infection—Part II, Curr. Probl. Surg., 17, 319 Meakins, 1977, Delayed hypersensitivity: Indicator of acquired failure of host defense in sepsis and trauma, Ann. Surg., 186, 241, 10.1097/00000658-197709000-00002 MacLean, 1975, Host resistance in sepsis and trauma, Ann. Surg., 182, 207, 10.1097/00000658-197509000-00004 Pietsch, 1977, The delayed hypersensitivity response: Application in clinical surgery, Surgery, 82, 349 Christou, 1979, Neutrophil function in patients: In vitro correction of abnormal neutrophil chemotaxis by levamisole, Surgery, 85, 543 Meakins, 1979, Therapeutic approaches to anergy in surgical patients: Surgery and levamisole, Ann. Surg., 190, 286, 10.1097/00000658-197909000-00003 Twomey, 1974, Cellular immunity in cured cancer patients, Cancer, 33, 435, 10.1002/1097-0142(197402)33:2<435::AID-CNCR2820330219>3.0.CO;2-A Payne, 1980, The value of lymphocyte transformation in carcinoma of the colon and rectum, Surg. Gynecol. Obstet., 150, 687 Marabella, 1975, Skin test with tumor extract in bronchogenic carcinomas: A preliminary study, J. Surg. Oncol., 7, 299, 10.1002/jso.2930070406 Stefani, 1976, Serial studies of immunocompetence in head and neck cancer patients undergoing radiation therapy, Am. J. Roentgenol., 126, 880, 10.2214/ajr.126.4.880 Marabella, 1975, Migration inhibition test in lung cancer patients, J. Surg. Oncol., 7, 479, 10.1002/jso.2930070607 Eilber, 1975, Sequential evaluation of general immune competence in cancer patients: Correlation with clinical course, Cancer, 35, 660, 10.1002/1097-0142(197503)35:3<660::AID-CNCR2820350319>3.0.CO;2-X Orita, 1976, Preoperative cell-mediated immune status of gastric cancer patients, Cancer, 38, 2343, 10.1002/1097-0142(197612)38:6<2343::AID-CNCR2820380621>3.0.CO;2-T Rebuck, 1955, A method of studying leukocyte functions in vivo, Ann. N.Y. Acad. Sci., 59, 757, 10.1111/j.1749-6632.1955.tb45983.x Christou N.V., Meakins J.L.: Partial analysis and purification of the polymorphonuclear chemotactic inhibitors in serum from anergic and reactive serum. Arch. Surg, in press. Bubenik, 1976, Neutrophil chemotaxis in surgical patients: Effect of cardiopulmonary bypass, Surg. Forum, 27, 267 Kaplan, 1968, Effects of cardiopulmonary bypass on the phagocytic capacity of polymorphonuclear leukocytes, Circulation, 37, 158, 10.1161/01.CIR.37.4S2.II-158 Donavan, 1967, The effect of surgery on reticuloendothelial cell function, Arch. Surg., 94, 247, 10.1001/archsurg.1967.01330080085022 Scovill, 1977, Disturbances in circulatory opsonic activity in man after operation and blunt trauma, J. Surg. Res., 22, 709, 10.1016/0022-4804(77)90113-5 Saba, 1978, Physiologic role of cold-insoluble globulin in systemic host defense: Implications of its characterization as the opsonic α2-surface-binding glycoprotein, Ann. N.Y. Acad. Sci., 312, 43, 10.1111/j.1749-6632.1978.tb16792.x Slade, 1975, Immunosuppression after major surgery in normal patients, Surgery, 78, 363 Pietsch, 1977, Delayed hypersensitivity responses: The effect of surgery, J. Surg. Res., 22, 228, 10.1016/0022-4804(77)90138-X Park, 1971, Immunosuppressive effect of surgery, Lancet, 1, 53, 10.1016/S0140-6736(71)90777-X Riddle, 1967, Postoperative depression of the lymphocyte response to phytohemagglutinin, Lancet, 1, 746, 10.1016/S0140-6736(67)91364-5 Han, 1972, Postoperative immunosuppression in patients with breast cancer, Lancet, 1, 742, 10.1016/S0140-6736(72)90248-6 Cochran, 1972, Postoperative depession of tumor-directed cell-mediated immunity in patients with malignant disease, Br. Med. J., 4, 67, 10.1136/bmj.4.5832.67 Meakins, 1979, Influence of cancer on host defense and susceptibility to infection, Surg. Forum, 30, 115 McLoughlin, 1979, Correlation between anergy and a circulating immunosuppressive factor following major surgical trauma, Ann. Surg., 190, 297, 10.1097/00000658-197909000-00004 Miller, 1976, Effect of surgery on the quantity of lymphocyte subpopulations, J. Surg. Res., 21, 155, 10.1016/0022-4804(76)90152-9 Humbert, 1976, Decreased neutrophil bactericidal activity in acute leukemia of childhood, Cancer, 37, 2194, 10.1002/1097-0142(197605)37:5<2194::AID-CNCR2820370506>3.0.CO;2-E Pickering, 1975, Leukocyte function in children with malignancies, Cancer, 35, 1365, 10.1002/1097-0142(197505)35:5<1365::AID-CNCR2820350519>3.0.CO;2-A McRipley, 1967, The role of the phagocyte in host-parasite interactions. V. Phagocytic and bactericidal activities of leukocytes from patients with different neoplastic disorders, Cancer Res., 27, 674 Sbarra, 1964, The role of the phagocyte in host-parasite interactions. I. The phagocytic capabilities of leukocytes from lymphoproliferative disorders, Cancer Res., 24, 1958 Sbarra, 1965, The role of the phagocyte in host-parasite interactions. III. The phagocytic capabilities of leukocytes from myeloproliferative and other neoplastic disorders, Cancer Res., 25, 1199 Chang, 1974, Nitroblue tetrazolium test in Hodgkin's disease and other malignant lymphomas, Arch. Intern. Med., 133, 401, 10.1001/archinte.133.3.401 Steigbigel, 1976, Polymorphonuclear leukocyte, monocyte, and macrophage bactericidal function in patients with Hodgkin's disease, J. Lab. Clin. Med., 88, 54 Hancock, 1976, Neutrophil function in lymphoreticular malignancy, Brit. J. Cancer, 33, 496, 10.1038/bjc.1976.80 Haim, 1977, Neutrophil function in cured cancer patients, Cancer, 40, 2273, 10.1002/1097-0142(197711)40:5<2273::AID-CNCR2820400538>3.0.CO;2-2 Groch, 1965, Reticuloendothelial phagocytic function in patients with leukemia, lymphoma, and multiple myeloma, Blood, 26, 489, 10.1182/blood.V26.4.489.489 Ruco, 1980, Increased monocyte phagocytosis in cancer patients, Eur. J. Cancer, 16, 1315, 10.1016/0014-2964(80)90288-1 Kleinerman, 1980, Defective monocyte killing in patients with malignancies and restoration of function during chemotherapy, Lancet, 2, 1102, 10.1016/S0140-6736(80)92540-4 Boetcher, 1974, Abnormal monocyte chemotactic response in cancer patients, J. Natl. Cancer Inst., 52, 1091, 10.1093/jnci/52.4.1091 Hausman, 1975, Defective monocyte function in patients with genitourinary cancer, J. Natl. Cancer Inst., 55, 1047, 10.1093/jnci/55.5.1047 Dizon, 1963, Abnormal cellular response to skin abrasion in cancer patients, Cancer, 16, 1288, 10.1002/1097-0142(196310)16:10<1288::AID-CNCR2820161009>3.0.CO;2-1 Steinherz, 1980, Influenza vaccination of children with neoplastic disease, Cancer, 45, 750, 10.1002/1097-0142(19800215)45:4<750::AID-CNCR2820450423>3.0.CO;2-Z Saslaw, 1961, Antibody response in hematologic patients, Proc. Soc. Exp. Biol. Med., 106, 654, 10.3181/00379727-106-26432 Aisenberg, 1963, Antibody formation in Hodgkin's disease, N. Engl. J. Med., 268, 1269, 10.1056/NEJM196306062682304 Hoffman, 1950, Studies of immunologic reactivity of patients, Arch. Int. Med., 86, 872 Brown, 1967, Hodgkin's disease. Immunologic, clinic, and histologic features of 50 untreated patients, Ann. Intern. Med., 67, 291, 10.7326/0003-4819-67-2-291 Robinson, 1981, Assays of immunocompetence in staging and prognosis of cancer, Surg. Gynecol. Obstet., 153, 909 Cataloria, 1975, Correlations among cutaneous reaction to DNCB, PHA-induced lymphocyte blastogenesis and peripheral blood E. rosettes, Clin. Exp. Immunol., 19, 327 Golub, 1974, Correlation of in vivo and in vitro assays of immunocompetence in cancer patients, Cancer Res, 34, 1833 Hinz, 1970, Quantitative aspects of the stimulation of lymphocytes by tuberculin purified protein derivative, Int. Arch. Appl. Immunol., 38, 119, 10.1159/000230265 Stein, 1976, Immunocompetence, immunosuppression, and human breast cancer, Cancer, 38, 1171, 10.1002/1097-0142(197609)38:3<1171::AID-CNCR2820380319>3.0.CO;2-8 Kelly, 1978, Anergy and skin homograft survival in Hodgkin's disease, Surg. Gynecol. Obstet., 107, 565 Kelly, 1960, An investigation of Hodgkin's disease with respect to the problem of homotransplantation, Ann. N. Y. Acad. Sci., 87, 187, 10.1111/j.1749-6632.1960.tb23192.x Sokal, 1961, The delayed skin test response in Hodgkin's disease and lymphosarcoma, Cancer, 14, 597, 10.1002/1097-0142(199005/06)14:3<597::AID-CNCR2820140321>3.0.CO;2-X Schier, 1954, Cutaneous anergy in Hodgkin's disease, N. Engl. J. Med., 250, 353, 10.1056/NEJM195403042500902 Schier, 1956, Hodgkin's disease and immunity, Am. J. Med., 20, 94, 10.1016/0002-9343(56)90176-0 Lamb, 1962, A comparative study of the incidence of anergy in patients with carcinoma, leukemia, Hodgkin's disease and other lymphomas, J. Immunol., 89, 556, 10.4049/jimmunol.89.4.555 Young, 1972, Delayed hypersensitivity in Hodgkin's disease: A study of 103 untreated patients, Am. J. Med., 52, 63, 10.1016/0002-9343(72)90008-3 Hersh, 1965, Impaired in vitro lymphocyte transformation in Hodgkin's disease, N. Engl. J. Med., 270, 1006, 10.1056/NEJM196511042731903 Levy, 1974, Impaired lymphocyte function in untreated Hodgkin's disease, N. Engl. J. Med., 290, 181, 10.1056/NEJM197401242900402 Han, 1970, Lymphocyte response to phytohemagglutinin in Hodgkin's disease, Am. J. Med., 48, 728, 10.1016/S0002-9343(70)80008-0 Winkelstein, 1974, Cellular immunity in Hodgkin's disease: Comparison of cutaneous reactivity and lymphoproliferative responses to phytohemagglutinin, Cancer, 34, 549, 10.1002/1097-0142(197409)34:3<549::AID-CNCR2820340312>3.0.CO;2-X Corder, 1972, Phytohemagglutinin-induced lymphocyte transformation: The relationship to prognosis of Hodgkin's disease, Blood, 39, 595, 10.1182/blood.V39.5.595.595 Bubrove, 1975, Quantitation of T and B lymphocytes and cellular immune function in Hodgkin's disease, Cancer, 36, 169, 10.1002/1097-0142(197507)36:1<169::AID-CNCR2820360115>3.0.CO;2-Z Gergely, 1973, Lymphocyte surface immunoglobulins in Hodgkin's disease, N. Engl. J. Med., 289, 220, 10.1056/NEJM197307262890421 Cohnen, 1973, Rosette-forming lymphocytes in Hodgkin's disease, N. Engl. J. Med., 289, 863, 10.1056/NEJM197310182891615 Kaszubowski, 1980, T-lymphocyte subpopulations in peripheral blood and tissues of cancer patients, Cancer Res, 40, 4648 Anthony, 1974, The prognostic significance of DHS skin tests in patients with carcinoma of bronchus, Cancer, 34, 1901, 10.1002/1097-0142(197412)34:6<1901::AID-CNCR2820340608>3.0.CO;2-P Krant, 1968, Immunologic alterations in bronchogenic cancer, Cancer, 21, 623, 10.1002/1097-0142(196804)21:4<623::AID-CNCR2820210414>3.0.CO;2-P Wanebo, 1976, Immune reactivity in primary cancer of the lung and its relation to prognosis, J. Thorac. Cardiovasc. Surg., 72, 339, 10.1016/S0022-5223(19)40060-3 Wells, 1973, Delayed cutaneous hypersensitivity reactions to tumor cell antigens and to nonspecific antigens, J. Thorac. Cardiovasc. Surg., 66, 557, 10.1016/S0022-5223(19)40589-8 Han, 1972, Immunologic impairment in bronchogenic carcinoma: A study of lymphocyte response to phytohemagglutinin, Cancer, 30, 616, 10.1002/1097-0142(197209)30:3<616::AID-CNCR2820300304>3.0.CO;2-Q Paty, 1973, Response to PHA in cancer patients, Lancet, 1, 668, 10.1016/S0140-6736(73)92235-6 Gross, 1975, Abnormal spontaneous rosette formation and rosette inhibition in lung carcinoma, N. Engl. J. Med., 292, 439, 10.1056/NEJM197502272920901 Olsson, 1972, Immunologic unreativity in bladder cancer patients, J. Urol., 107, 607, 10.1016/S0022-5347(17)61090-5 Shellhammer, 1976, Immune evaluation with skin testing: A study of testicular, prostatic and bladder neoplasm, Cancer, 38, 149, 10.1002/1097-0142(197607)38:1<149::AID-CNCR2820380124>3.0.CO;2-Q Catalona, 1974, Abnormalities of cell-mediated immunocompetence in genitourinary cancer, J. Urol., 111, 229, 10.1016/S0022-5347(17)59935-8 Catalona, 1974, Lymphocyte stimulation in urologic cancer patients, J. Urol., 112, 373, 10.1016/S0022-5347(17)59734-7 Catalona, 1974, T-lymphocytes in bladder and prostatic cancer patients, J. Urol., 112, 378, 10.1016/S0022-5347(17)59735-9 Eilber, 1972, Impaired immunologic reactivity and recurrence following cancer surgery, Cancer, 25, 362, 10.1002/1097-0142(197002)25:2<362::AID-CNCR2820250213>3.0.CO;2-V Golub, 1974, Correlation of in vivo and in vitro assays of immunocompetence in cancer patients, Cancer Res, 34, 1883 Pritchard, 1978, A prospective study of immune responsiveness in human melanoma. I. Assessment of initial pretreatment status with stage of disease, Cancer, 41, 2165, 10.1002/1097-0142(197806)41:6<2165::AID-CNCR2820410615>3.0.CO;2-N Lieberman, 1974, Immunologic changes in patients with cutaneous malignant melanoma following intratumoral inoculation of BCG: Correlation with cell-mediated immunity, Int. J. Cancer, 14, 401, 10.1002/ijc.2910140315 Bosworth, 1976, Delayed hypersensitivity and local control of patients treated by radiotherapy for head and neck cancer, Am. J. Surg., 132, 46, 10.1016/0002-9610(76)90288-9 Brooks, 1972, Depressed cell-mediated immunity in patients with primary intracranial tumors, J. Exp. Med., 136, 1631, 10.1084/jem.136.6.1631 Cheema, 1971, Patient survival after chemotherapy and its relationship to in vitro blastogenesis, Cancer, 28, 851, 10.1002/1097-0142(1971)28:4<851::AID-CNCR2820280408>3.0.CO;2-E Sterling, 1973, Lymphocyte transformation to phytohemagglutinin and delayed hypersensitivity related to age and previous cancer history, Clin. Exp. Immunol., 37, 352 Butterworth, 1974, T-lymphocyte responses in patients with malignant melanoma, Eur. J. Cancer., 10, 639, 10.1016/0014-2964(74)90002-4 Cosimi, 1973, Cellular immune competence of breast cancer patients receiving radiotherapy, Arch. Surg., 107, 531, 10.1001/archsurg.1973.01350220015005 Garrioch, 1970, Lymphocyte response to PHA in patients with non-lymphoid tumors, Lancet, 1, 618, 10.1016/S0140-6736(70)91658-2 Whittaker, 1971, Reduced lymphocyte transformation in breast cancer, Lancet, 1, 892, 10.1016/S0140-6736(71)92448-2 Nemoto, 1974, Cell-mediated immune status of breast cancer patients: Evaluation by skin tests, lymphocyte stimulation, and counts of rosette-forming cells, J. Natl. Cancer. Inst., 53, 641, 10.1093/jnci/53.3.641 Chretien, 1973, Correlation of preoperative lymphocyte reactivity with clinical course of cancer patients, Surg. Gynecol. Obstet., 136, 380 Wybran, 1973, Thymus-derived rosette-forming cells in various human disease states: Cancer, lymphoma, bacterial and viral infections, and other disease, J. Clin. Invest., 52, 1026, 10.1172/JCI107267 Olkowski, 1975, T-lymphocyte levels in the peripheral blood of patients with cancer of the head and neck, Am. J. Surg., 130, 440, 10.1016/0002-9610(75)90481-X Kerman, 1976, Active T-rosette-forming cells in the peripheral blood of cancer patients, Cancer Res., 36, 3274 Dellon, 1975, Thymus-dependent lymphocyte levels in bronchogenic carcinoma: Correlations with histology, clinical stage, and clinical course after surgical treatmen, Cancer, 35, 687, 10.1002/1097-0142(197503)35:3<687::AID-CNCR2820350322>3.0.CO;2-U Potvin, 1975, Thymus-derived lymphocytes in patients with solid malignancies, Clin. Exp. Immunol., 3, 476 Lichtenstein, 1980, Comparison of immune derangements in patients with different malignancies, Cancer, 45, 2090, 10.1002/1097-0142(19800415)45:8<2090::AID-CNCR2820450816>3.0.CO;2-O Koziner, 1975, Distribution of latex-ingesting cells, T cells and B cells in the peripheral blood of patients with malignant melanoma, J. Natl. Cancer. Inst., 55, 1295, 10.1093/jnci/55.6.1295 Quan, 1978, Demonstration of nonspecific suppressor cells in the peripheral lymphocytes of cancer patients, Cancer Res., 38, 288 Braun, 1980, Multiple concurrent immunoregulatory defects in cancer patients with depressed PHA-induced lymphocyte DNA synthesis, Clin. Immunol. Immunopathol., 17, 89, 10.1016/0090-1229(80)90076-8 Zembala, 1977, Depressed in vitro peripheral blood lymphocyte response to mitogens in cancer patients: The role of suppressor cells, Int. J. Cancer, 19, 605, 10.1002/ijc.2910190503 Catalona, 1973, Lymphocyte reactivity in cancer patients: Correlation with tumor histology and clinical stage, Cancer, 31, 65, 10.1002/1097-0142(197301)31:1<65::AID-CNCR2820310109>3.0.CO;2-Y Sample, 1971, Inhibition of phytohemagglutinin-induced lymphocyte transformation by serum from patients with carcinoma, J. Natl. Cancer. Inst., 46, 1291 Edwards, 1973, Reduction of lymphocyte transformation by a factor produced by gastrointestinal cancer, Lancet, 1, 687, 10.1016/S0140-6736(73)91477-3 Silk, 1967, Effect of plasma from patients with carcinoma on in vitro lymphocyte transformation, Cancer, 20, 2088, 10.1002/1097-0142(196712)20:12<2088::AID-CNCR2820201205>3.0.CO;2-1 Suciu-Fuca, 1973, Impaired responsiveness of lymphocytes and serum-inhibitory factors in patients with cancer, Cancer Res., 33, 2373 Trubowitz, 1966, Lymphocyte response to phytohemagglutinin in Hodgkin's disease, lymphatic leukemia, and lymphosarcoma, Cancer, 19, 2019, 10.1002/1097-0142(196612)19:12<2019::AID-CNCR2820191228>3.0.CO;2-H